May 7, 2020 / 9:40 PM / 23 days ago

BRIEF-Mirum Pharmaceuticals Reports First Quarter 2020 Financial Results

May 7 (Reuters) - Mirum Pharmaceuticals Inc:

* MIRUM PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

* MIRUM PHARMACEUTICALS INC - CASH, CASH EQUIVALENTS AND INVESTMENTS BALANCE OF $166.1 MILLION

* MIRUM PHARMACEUTICALS - WITHDRAWING PREVIOUS GUIDANCE REGARDING TIMING OF INITIATION & ENROLLMENT OF ONGOING & PLANNED MARALIXIBAT & VOLIXIBAT STUDIES

* MIRUM PHARMACEUTICALS INC - PLANNED TIMELINE FOR SUBMISSION OF ITS NDA FOR MARALIXIBAT IN ALGS HAS NOT BEEN IMPACTED

* MIRUM PHARMACEUTICALS - CONTINUES TO COLLECT DATA IN INDIGO STUDY, IN WHICH PFIC2 PATIENTS HAVE BEEN TREATED WITH MARALIXIBAT FOR MORE THAN 5 YEARS

* MIRUM PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.86 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below